Sim SH - Search Results

1

Comprehensive somatic genome alterations of urachal carcinoma.

Lee S, Lee J, Sim SH, Lee Y, Moon KC, Lee C, Park WY, Kim NK, Lee SH, Lee H. Lee S, et al. Among authors: sim sh. J Med Genet. 2017 Aug;54(8):572-578. doi: 10.1136/jmedgenet-2016-104390. Epub 2017 Mar 27. J Med Genet. 2017. PMID: 28348108

2

Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma.

Sim SH, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Kim TY, Lee JS, Kim YW, Heo DS, Bang YJ. Sim SH, et al. Lung Cancer. 2009 Aug;65(2):204-7. doi: 10.1016/j.lungcan.2008.11.006. Epub 2008 Dec 24. Lung Cancer. 2009. PMID: 19110337

3

The role of PET/CT in detection of gastric cancer recurrence.

Sim SH, Kim YJ, Oh DY, Lee SH, Kim DW, Kang WJ, Im SA, Kim TY, Kim WH, Heo DS, Bang YJ. Sim SH, et al. BMC Cancer. 2009 Mar 1;9:73. doi: 10.1186/1471-2407-9-73. BMC Cancer. 2009. PMID: 19250554 Free PMC article.

4

Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer.

Sim SH, Ahn YO, Yoon J, Kim TM, Lee SH, Kim DW, Heo DS. Sim SH, et al. Cancer Sci. 2012 Feb;103(2):155-60. doi: 10.1111/j.1349-7006.2011.02158.x. Epub 2011 Dec 23. Cancer Sci. 2012. PMID: 22107611 Free article.

5

Application of cancer genomics to solve unmet clinical needs.

Lee SH, Sim SH, Kim JY, Cha S, Song A. Lee SH, et al. Among authors: sim sh. Genomics Inform. 2013 Dec;11(4):174-9. doi: 10.5808/GI.2013.11.4.174. Epub 2013 Dec 31. Genomics Inform. 2013. PMID: 24465227 Free PMC article. Review.

6

Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis.

Kim YJ, Kim SJ, Lee JK, Choi WS, Park JH, Kim HJ, Sim SH, Lee KW, Lee SH, Kim JH, Kim DW, Lee JS, Bang YJ, Heo DS. Kim YJ, et al. Among authors: sim sh. J Cancer Res Clin Oncol. 2014 Sep;140(9):1567-74. doi: 10.1007/s00432-014-1688-1. Epub 2014 May 4. J Cancer Res Clin Oncol. 2014. PMID: 24793643

7

The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer.

Sim SH, Keam B, Kim DW, Kim TM, Lee SH, Chung DH, Heo DS. Sim SH, et al. J Cancer Res Clin Oncol. 2014 Dec;140(12):2135-42. doi: 10.1007/s00432-014-1768-2. Epub 2014 Jul 9. J Cancer Res Clin Oncol. 2014. PMID: 25005787

8

Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer.

Sim SH, Kim YJ, Kim SH, Keam B, Kim TM, Lee SH, Kim DW, Heo DS, Lee JS. Sim SH, et al. J Cancer Res Clin Oncol. 2015 Jun;141(6):1073-81. doi: 10.1007/s00432-014-1875-0. Epub 2014 Nov 20. J Cancer Res Clin Oncol. 2015. PMID: 25410789

9

Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients.

Beom SH, Kim DW, Sim SH, Keam B, Park JH, Lee JO, Kim TM, Lee SH, Heo DS. Beom SH, et al. Among authors: sim sh. Cancer Res Treat. 2016 Jan;48(1):88-97. doi: 10.4143/crt.2014.201. Epub 2015 Mar 3. Cancer Res Treat. 2016. PMID: 25761482 Free PMC article.

10

Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.

Cha S, Lee J, Shin JY, Kim JY, Sim SH, Keam B, Kim TM, Kim DW, Heo DS, Lee SH, Kim JI. Cha S, et al. Among authors: sim sh. BMC Cancer. 2016 Feb 29;16:170. doi: 10.1186/s12885-016-2209-1. BMC Cancer. 2016. PMID: 26925973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page